A Rare Case of Perrault Syndrome with Auditory Neuropathy Spectrum Disorder: Cochlear Implantation Treatment and Literature Review.
Francesca ForliLuca BruschiniBeatrice FranciosiRoberta BattiniGemma MarinellaStefano BerrettiniFrancesco LazzeriniPublished in: Audiology research (2021)
Perrault syndrome (PRLTS) is a rare autosomal recessive disorder characterised by ovarian failure in females and sensorineural hearing loss (SNHL) in both genders. In the present paper we describe a child affected by PRLTS3, due to CLPP homozygous mutations, presenting auditory neuropathy spectrum disorder (ANSD) with bilateral progressive SNHL. This is the first case reported in the literature of an ANSD in PRLTS3. CLPP is a nuclear encoded mitochondrial protease directed at the mitochondrial matrix. It is encoded on chromosome 19. This protease participates in mitochondrial protein quality control by degrading misfolded or damaged proteins, thus maintaining the normal metabolic function of the cell. In PRLTS3, the peptidase activity of CLPP is suppressed. Neurological impairments involved in PRLTS3 suggest that the pathogenic mutations in CLPP might trigger a mitochondrial dysfunction. A comprehensive description of the clinical and audiological presentation, as well as the issues related to cochlear implant (CI) procedure and the results, are addressed and discussed. A brief review of the literature on this topic is also provided.
Keyphrases
- spectrum disorder
- case report
- rare case
- quality control
- oxidative stress
- working memory
- systematic review
- multiple sclerosis
- single cell
- minimally invasive
- stem cells
- blood brain barrier
- cell therapy
- protein protein
- combination therapy
- binding protein
- dna methylation
- subarachnoid hemorrhage
- duchenne muscular dystrophy